# Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions

> **NCT01884896** · PHASE1 · COMPLETED · sponsor: **IPCA Laboratories Ltd.** · enrollment: 48 (actual)

## Conditions studied

- Fasting

## Interventions

- **DRUG:** Metoprolol Succinate ER Tablet 200 mg
- **DRUG:** 'TOPROL-XL®' ER Tablets 200 mg

## Key facts

- **NCT ID:** NCT01884896
- **Lead sponsor:** IPCA Laboratories Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2013-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01884896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01884896, "Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01884896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*